Illumina (NASDAQ: ILMN) delivered strong revenue and earnings growth the last time it reported quarterly results in October. In particular, the gene-sequencing leader posted great sequencing system sales -- the highest in three years.
The company announces its full-year 2018 and fourth-quarter financial results after the market closes on Tuesday, Jan. 29, 2019.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,